Skip to main content

and
  1. Article

    Open Access

    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

    Saskia Hell, Madlen Jentzsch, Georg-Nikolaus Franke in Bone Marrow Transplantation (2022)

  2. No Access

    Article

    Nicotinamide Inhibits Self-renewal and Induces Granulocyte Differentiation of Multipotent Progenitor Cells

    Nicotinamide (NAM) a form of vitamin B3, is an essential precursor of NAD. This dinucleotide (pyridine nucleotide) participates in the regulation of fundamental processes including transcription, cell cycle pr...

    Waseem Nasr, Claire Fabian, Katrin Arnold, Ulrike Köhl in Stem Cell Reviews and Reports (2020)

  3. No Access

    Article

    Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation

    Age-related somatic mutations linked to clonal hematopoiesis have been found in apparently healthy individuals and increase the risk of develo** hematologic malignancies. In acute myeloid leukemia (AML) the ...

    Juliane Grimm, Marius Bill, Madlen Jentzsch in Bone Marrow Transplantation (2019)

  4. No Access

    Article

    Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation

    Laura K. Schmalbrock, Lynn Bonifacio, Marius Bill in Bone Marrow Transplantation (2018)

  5. No Access

    Chapter

    MSCs: Clinical Applications and European Regulatory Aspects

    Mesenchymal stromal/stem cells (MSCs) are used to treat a wide variety of diseases. The conditions for which MSCs are administered are often rare and provide an unmet medical need. The biology of MSCs, however...

    Jens Reinhardt, Egbert Flory, Isabel Büttel, Christa Schröder in Mesenchymal Stromal Cells (2013)